Navigation Links
Kidney Patients Risk Heart Attacks

A new study shows kidney patients have far more to be concerned about than only their kidneys. The American Heart Association-sponsored study shows //people with chronic kidney disease are in the highest risk group for heart disease. Doctors say the most surprising finding was that this also applies to people who are in the very early stages of kidney disease.

Doctors have known patients in end-stage renal disease have a greater risk of heart attacks. Researchers from Tufts-New England Medical Center in Boston say their concern is for the 20 million Americans who have early kidney disease. That group along with the number of people with advanced kidney disease is alarming. The number of people with kidney failure treated by dialysis is expected to surpass 650,000 by the year 2010.

From these findings, the researchers urge all doctors to be aware that kidney patients fall into the highest risk category for cardiovascular disease. The American Heart Association also recommends physicians periodically test the kidney function of people with certain conditions including high blood pressure, diabetes and existing heart disease. From there, treatment can be started early. Mark Sarnak, M.D., co-author of the study, is quoted as saying, "There are some very good treatments for kidney disease, and fortunately, there isn’t a medication that is good for the kidney that is bad for the heart."

They also say more research is needed. Specifically, the study authors are calling for randomized controlled studies of treatments for heart disease in chronic kidney disease patients
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Kidney Stones - Interesting New Research implicates bacteria as its cause
3. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
4. New Dietary Approach To Manage Kidney Stones
5. Kidney cancer on the rise
6. Kidney function can be affected by lead exposure
7. Kidney Failure after Non-Kidney Transplants
8. Kidney Patients Risk Heart Attacks
9. Urine Test for Kidney Cancer
10. New Hope for Kidney Failure
11. Hope for Patients With Kidney Failure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Kidney Patients Risk Heart Attacks

(Date:12/2/2009)... , WHITE PLAINS, N.Y., Dec. 2 /PRNewswire-US...l present their findings in blood cancer research ... conference in New Orleans December 4-8, 2009. ,...mp; Lymphoma Society (LLS) experts, including Chie...r Vice President of Patient Services Hildy Dillon,...
(Date:12/2/2009)... , PHILADELPHIA, Dec. 2 Inde...health benefits contract with Lincoln Financial Gr...surance for approximately 10,000 Lincoln Financial...cross the nation. The Lincoln plan offerings will ...ical plans. ,, "I know I speak for all of us at...
(Date:12/2/2009)...ltham, MAJoseph Balboni loves sports. An avid tenn... 46-year-old insurance agent became increasingly f...keratoconus, a degenerative eye disorder. Unable t...ox games, he faced the prospect of a corneal trans...hen three years ago, Balboni discovered an alterna...
(Date:12/2/2009)... National Pen ( www.pens.com ...er, announced today it is giving away 10,000 free ...WEB) December 2, 2009 -- National Pen ( www.pens.c...ailer announced today it is giving away 10,000 fre...ew way to promote business that no other company i...
(Date:12/2/2009)... On Sunday, more than 900 run...ntry will cross the finish line at the Rock &lsquo...Zappos.com, raising over $3.2 million for the Croh...thon training program, Team Challenge (www.ccteamc...e funds will go toward research, education, and su...
Breaking Medicine News(10 mins):Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4
...announces the launch of their new website www.Gla...introduce the Physician marketplace to Glenwood Sy...agement/billing system GlaceComplete as well as p...Systems LLC announces the launch of their new webs...
...eve symptoms of cough and congestion, may be harmf...g in the January issue of CHEST , the peer-review...ians (ACCP), shows that Vicks VapoRub (VVR) may st... with current VVR labeling which indicates the pro...
... District Court Decision , , VANCOUVER, Jan. 12 /... TSX: QLT) announced that the United States Court ...peals") today affirmed the judgment of the United ...ry ("MEEI") in connection with events related to U...
...Groups Calls for CER to Include Consideration of D...SHINGTON, Jan. 12 Federally-supported comparative...improve health care decision-making, and must be s...ident-elect Obama and congressional leaders, PIPC ...
...of the widely used guideline , , MONDAY, J...le aged 50 and younger who have a low 10-year risk...d Framingham Risk Score may still have a high life...question the Framingham Risk Score,s ability to ac...
...rporated (NYSE: DGX ), the world,s leading provi...s, announced today that it will report fourth-quar...al guidance for 2009 on Monday, January 26, before...blic may access the conference call through a live...
Other Medicine News:Health News:Glenwood Systems, LLC Launches New Website -- GlaceComplete.com 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 3Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 2Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 2Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 4Health News:Framingham Score May Not Spot Lifetime Heart Risk 2Health News:Framingham Score May Not Spot Lifetime Heart Risk 3Health News:Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results 2
(Date:12/2/2009)...ANTON, Calif., Dec. 2 Ro...hat the United States Food & Drug Administrati...ts licensed nucleic acid test, to screen source pl...ations. The test, called the cobas® TaqScreen...a qualitative, in-vitro test for the simultaneous,...
(Date:12/2/2009)..., EAST HANOVER, N.J., Dec. 2 Nova...te-breaking presentation on Tasigna® (nilotin...eukemia, demonstrate the strength of the company,s...ients. ,, The new data, at the 51st American S...sition, highlight the company,s current therapies ...
(Date:12/1/2009)...O BEACH, Calif., Dec. 1 Reproducti...ective Single Embryo Transfer (eSET) Encouragement...ents with good embryo quality and a good prognosis...ins by transferring a single embryo. ,, The big...ay is reducing the number of multiple pregnancies,...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Supply Chain Council Announces New Board of Directors and Officers 9218 1UK Identity and Passport Service and IBM Sign 7 year National Biometric Identity Service 28NBIS 29 Contract 9215 1UK Identity and Passport Service and IBM Sign 7 year National Biometric Identity Service 28NBIS 29 Contract 9215 2How to De Stress a Recession Riddled Life 51398 1How to De Stress a Recession Riddled Life 51398 2How to De Stress a Recession Riddled Life 51398 3
... review programs need more,money, WASHINGTON, Marc...te by the Alzheimer,s Association shows that more ...mer,s disease -- a 10,percent growth over previous...e in the coming decades unless new treatments and ..., The new numbers re-emphasize the need for a stro...
... in Peer-Review Journal,Respiratory Medicine, SAN ...oalition,for Pulmonary Fibrosis (CPF) today announ...uestionnaire, considered one of the,largest databa...pathic pulmonary fibrosis (IPF) in the United Stat...lication is an,internationally-renowned, peer-revi...
Other Medicine Technology:Alzheimer's Growth Shows Need for Increased FDA Funding 2Alzheimer's Growth Shows Need for Increased FDA Funding 3Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 2Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 3
Advance Posterior Stabilized Total Knee Systems
Alpina Total Knee Prosthesis
Scorpio CR Knee, cruciate retaining single axis
...UC-Plus Solution knee is the state of the art prod...nt. Geometry of the articular surfaces does not re...mical variations, and achieves a wide area of cont...ge, uninterrupted pockets of cement create a homog...
Medicine Products: